[The vasoactive effects of captopril (SQ 14225). Preliminary research]. 1981

N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito

The Authors examined the behaviour of the humeral arterial pressure, of the heart frequency and of the muscular blood flow in inferior limbs. This study was performed before and after treatment with Captopril (SQ 14225), 100 mg per os, a selective inhibitor of the converting enzyme. Both resting blood flow (RBF) and maximal blood flow (NBF) were studied by Xenon 133 clearance. The A.A. observed that the drug induced a significant (P less than 0.01) increase of both RBF and MBF. Therefore, the Authors hypothesize that the Captopril is able to produce peripheral vasodilatation, without any significant variation of the cardiac index and frequency. Such an effect is considered to depend not only upon the inhibited angiotensin II production, but also upon stimulation of bradikinins and prostaglandins.

UI MeSH Term Description Entries
D008297 Male Males
D011392 Proline A non-essential amino acid that is synthesized from GLUTAMIC ACID. It is an essential component of COLLAGEN and is important for proper functioning of joints and tendons. L-Proline,L Proline
D001783 Blood Flow Velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed. Blood Flow Velocities,Flow Velocities, Blood,Flow Velocity, Blood,Velocities, Blood Flow,Velocity, Blood Flow
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014664 Vasodilation The physiological widening of BLOOD VESSELS by relaxing the underlying VASCULAR SMOOTH MUSCLE. Vasodilatation,Vasorelaxation,Vascular Endothelium-Dependent Relaxation,Endothelium-Dependent Relaxation, Vascular,Relaxation, Vascular Endothelium-Dependent,Vascular Endothelium Dependent Relaxation

Related Publications

N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
December 1981, Clinical nephrology,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
January 1979, Nihon rinsho. Japanese journal of clinical medicine,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
November 1980, The Tohoku journal of experimental medicine,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
January 1995, European journal of ophthalmology,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
October 1981, Nihon Jinzo Gakkai shi,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
October 1979, Nature,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
August 1981, International journal of clinical pharmacology, therapy, and toxicology,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
October 1980, European journal of pharmacology,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
November 1980, Japanese heart journal,
N Frisina, and M Buemi, and F Vitulo, and A Lasco, and O Ciraolo, and V Nicita-Mauro, and N Bonanno, and G Squadrito
September 1980, The Tohoku journal of experimental medicine,
Copied contents to your clipboard!